New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Study: Children with hypertension at higher long-term risk for serious heart conditions

Study: Children with hypertension at higher long-term risk for serious heart conditions

byAmerican Pediatric SocietyCredit: Unsplash/CC0 Public DomainYouth with high blood pressure are nearly four times more likely to be at long-term risk of serious heart conditions including strok
Cardiovascular Diseases May 08,2024
Study: Children with hypertension at higher long-term risk for serious heart conditions

Study: Children with hypertension at higher long-term risk for serious heart conditions

byAmerican Pediatric SocietyCredit: Unsplash/CC0 Public DomainYouth with high blood pressure are nearly four times more likely to be at long-term risk of serious heart conditions including strok
Cardiovascular Diseases May 08,2024
Biological engineers discover why a promising drug failed in clinical trials

Biological engineers discover why a promising drug failed in clinical trials

by Anne Trafton,Massachusetts Institute of TechnologyRheumatoid arthritis, which afflicts more than 1 million Americans, is an autoimmune disorder that produces swollen and painful joints, prima
Breakthroughs May 08,2024
Biological engineers discover why a promising drug failed in clinical trials

Biological engineers discover why a promising drug failed in clinical trials

by Anne Trafton,Massachusetts Institute of TechnologyRheumatoid arthritis, which afflicts more than 1 million Americans, is an autoimmune disorder that produces swollen and painful joints, prima
Breakthroughs May 08,2024
Novel thrombectomy system demonstrates positive safety and feasibility results in treating acute pulmonary embolism

Novel thrombectomy system demonstrates positive safety and feasibility results in treating acute pulmonary embolism

bySociety for Cardiovascular Angiography and InterventionsCredit: Pixabay/CC0 Public DomainLate-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effect
Cardiovascular Diseases May 08,2024
Novel thrombectomy system demonstrates positive safety and feasibility results in treating acute pulmonary embolism

Novel thrombectomy system demonstrates positive safety and feasibility results in treating acute pulmonary embolism

bySociety for Cardiovascular Angiography and InterventionsCredit: Pixabay/CC0 Public DomainLate-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effect
Cardiovascular Diseases May 08,2024
New study indicates why children are likelier to develop food allergies

New study indicates why children are likelier to develop food allergies

by La Jolla Institute for Allergy and ImmunologyA study by LJI researchers identified a T cell population that renders normal food non-allergenic. Credit: La Jolla Institute for Allergy and Immun
Immunology & Rheumatology May 08,2024
New study indicates why children are likelier to develop food allergies

New study indicates why children are likelier to develop food allergies

by La Jolla Institute for Allergy and ImmunologyA study by LJI researchers identified a T cell population that renders normal food non-allergenic. Credit: La Jolla Institute for Allergy and Immun
Immunology & Rheumatology May 08,2024
Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial

Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial

by American Thoracic SocietyObstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale R
Immunology & Rheumatology May 08,2024
Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial

Tezepelumab significantly reduced asthma exacerbations: Phase 3 NAVIGATOR trial

by American Thoracic SocietyObstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale R
Immunology & Rheumatology May 08,2024
A new pathway to 'reprogram' killer cells

A new pathway to 'reprogram' killer cells

by University of BernNK cells (brown) patrolling between cells of a healthy human lymph node. Credit: Institute of Pathology, University of BernThe so-called natural killer (NK) cells are cells o
Immunology & Rheumatology May 08,2024
A new pathway to 'reprogram' killer cells

A new pathway to 'reprogram' killer cells

by University of BernNK cells (brown) patrolling between cells of a healthy human lymph node. Credit: Institute of Pathology, University of BernThe so-called natural killer (NK) cells are cells o
Immunology & Rheumatology May 08,2024
A near-fatal Valley Fever case opens doors to new treatment method

A near-fatal Valley Fever case opens doors to new treatment method

by Ryan Hatoum,University of California, Los AngelesAbraham Gonzalez-Martinez, who had a dangerous case of Valley Fever, at UCLA Mattel Children’s Hospital. Credit: University of California, Los
Immunology & Rheumatology May 08,2024
A near-fatal Valley Fever case opens doors to new treatment method

A near-fatal Valley Fever case opens doors to new treatment method

by Ryan Hatoum,University of California, Los AngelesAbraham Gonzalez-Martinez, who had a dangerous case of Valley Fever, at UCLA Mattel Children’s Hospital. Credit: University of California, Los
Immunology & Rheumatology May 08,2024
T cell response not critical for immune memory to SARS-CoV-2 or recovery from COVID-19

T cell response not critical for immune memory to SARS-CoV-2 or recovery from COVID-19

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDNew research conducted in monkeys reveals that T cells are
Immunology & Rheumatology May 08,2024
T cell response not critical for immune memory to SARS-CoV-2 or recovery from COVID-19

T cell response not critical for immune memory to SARS-CoV-2 or recovery from COVID-19

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDNew research conducted in monkeys reveals that T cells are
Immunology & Rheumatology May 08,2024
Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy

Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy

by Universidad de NavarraStudy proposes a new therapeutic approach against cancer that dissociates efficacy and toxicity in the use of combined immunotherapy in animal models. This clinical strat
Immunology & Rheumatology May 08,2024
Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy

Pretreatment with TNF inhibitors may improve outcomes of combination cancer immunotherapy

by Universidad de NavarraStudy proposes a new therapeutic approach against cancer that dissociates efficacy and toxicity in the use of combined immunotherapy in animal models. This clinical strat
Immunology & Rheumatology May 08,2024
Some severe COVID-19 cases linked to genetic mutations or antibodies that attack the body

Some severe COVID-19 cases linked to genetic mutations or antibodies that attack the body

by Howard Hughes Medical InstituteInfection with the novel coronavirus (gold spheres) can cause a range of symptoms. Some people with severe cases of COVID-19 have genetic mutations in key immuni
Immunology & Rheumatology May 08,2024
Some severe COVID-19 cases linked to genetic mutations or antibodies that attack the body

Some severe COVID-19 cases linked to genetic mutations or antibodies that attack the body

by Howard Hughes Medical InstituteInfection with the novel coronavirus (gold spheres) can cause a range of symptoms. Some people with severe cases of COVID-19 have genetic mutations in key immuni
Immunology & Rheumatology May 08,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com